Evidence-based recommendations for local-regional control of gastric cancer

Cancer Investigation

Volumn 23, Issue 4, 2005, Pages 352-362

  Hundahl, Scott A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

Chemo radiation; Clinical trials; D 0; Evidence based; Gastric cancer; Lymph nodes; Lymphadenectomy; Maruyama index; Maruyama program; Staging

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SURVIVAL; CHEMOTHERAPY; CLINICAL TRIAL; DRUG DOSE REDUCTION; EVIDENCE BASED MEDICINE; HUMAN; LYMPH NODE; LYMPHADENECTOMY; META ANALYSIS; PARTIAL GASTRECTOMY; PRIORITY JOURNAL; SHORT SURVEY; STOMACH CANCER; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TOTAL STOMACH RESECTION; CONTROLLED CLINICAL TRIAL; HEALTH CARE QUALITY; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STANDARD; STOMACH TUMOR; SURVIVAL; UNITED STATES;

COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; LYMPHATIC METASTASIS; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 24744431889     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1081/CNV-58885     Document Type: Short Survey

References (101)

1. McNeer, G.; Sunderlund, D.; McInnes, G. A more thorough operation for gastric cancer: anatomical basis and description of technique. Cancer 1951, 4, 957-967.
2. Lewis, F.; Wangensteen, O. Exploration following resection of the colon, rectum, or stomach for carcinoma with lymph node metastases. Surg. Forum 1950, 1950, 535-540.
3. Remine, W.; Priestley, L. Late results after total gastrectomy. Surg. Gynecol. Obstet. 1952, 94, 519-525.
4. McNeer, G.; Pack, G. Neoplasms of the Stomach; Lippincott: Philadelphia, 1967.
5. Gilbertson, V. Results of treatment of stomach cancer: an appraisal of efforts for more extensive surgery and a report of 1,983 cases. Cancer 1969, 23, 1305-1308.
6. Kajitani, T. The general rules for the gastric cancer study in surgery and pathology. I. Part, Clinical classification. Jpn. J. Surg. 1981, 11, 127-139.
7. Kajitani, T.; Hoshino, T. Studies on five-year survivals after surgery for gastric carcinoma. Rev. Surg. 1965, 22, 398-399.
8. Kajitani, T.; Nishi, M. Surgical treatment of gastric cancer: pyloric gastrectomy. Gan No Rinsho 1972 (Suppl.), 269-274.
9. Nakajima, T.; Kajitani, T. Surgical treatment of gastric cancer with special reference to lymph node dissection. In Diagnosis and Treatment of Upper Gastrointestinal Tumors; Friedman, M., Ogawa, M., Kisner, D., Eds.; Excerpta Medica: Amsterdam, 1981; 207-223.
10. Takagi, K.; Nishi, M.; Kajitani, T. Surgical treatment of gastric cancer today. Wien Klin. Wochenschr. 1987, 99, 410-415.
11. Nakajima, T.; Fukami, A.; Ohashi, I.; Kajitani, T. Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C. Int. J. Clin. Pharmacol. Biopharm. 1978, 16, 209-216.
12. Ohta, K.; Nishi, M.; Nakajima, T.; Kajitani, T. Indications for total gastrectomy combined with pancreaticosplenectomy in the treatment of middle gastric cancer. Nippon Geka Gakkaishi 1989, 90, 1326-1330.
13. Maruyama, K.; Okabayashi, K.; Kinoshita, T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J. Surg. 1987, 11, 418-425.
14. Watanabe, S.; Arimoto, H. Standardized mortality rates of cancer by prefecture in 1979-1981 and 1984-1986 in Japan. Jpn. J. Clin. Oncol. 1990, 20, 316-337.
15. Davis, D.L.; Hoel, D.; Fox, J.; Lopez, A. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 1990, 336, 474-481.
16. The Third Japan-US Conference on Biostatistics in the Study of Human Cancer. November 11-13, 1988, Hiroshima, Japan. Proc. Environ. Health Perspect. 1990, 87, 1-178.
17. Nagata, T.; Ikeda, M.; Nakayama, F. Changing state of gastric cancer in Japan. Histologic perspective of the past 76 years. Am. J. Surg. 1983, 145, 226-233.
18. Maruyama, K.; Gunven, P.; Okabayashi, K.; Sasako, M.; Kinoshita, T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann. Surg. 1989, 210, 596-602.
19. Maruyama, K.; Sasako, M.; Kinoshita, T. Wert der systematischen erweiterten Lymphknotendissektion-Ergebnisse in Japan. (Value of systematic extended lymph node dissection-results in Japan). Langenbecks Arch. Chir., Kongr.bd. 1992, 130-135.
20. Sakakibara, N.; Asakura, A. Evaluation of 5-year survival after extensive radical surgery for gastric carcinoma. Geka Chiryo 1966, 15, 156-161.
21. Kodama, Y.; Kano, T.; Tamada, R.; Kumashiro, R.; Okamura, T.; Inokuchi, K. Combined effect of prophylactic lymphadenectomy and long term combination chemotherapy for curatively resected carcinoma of the stomach. Jpn. J. Surg. 1982, 12, 244-248.
22. Kaibara, N.; Okamoto, T.; Kimura, O.; et al. Possible role of lymph node dissection in the surgical treatment of gastric cancer with disseminating peritoneal metastasis. Jpn. J. Surg. 1983, 13, 404-408.
23. The general rules for gastric cancer study in surgery. Jpn. J. Surg. 1973, 3, 61-71.
24. Manual for Staging of Cancer, 2nd Ed.; Beahrs, O.H., Meyers, M.H., Eds.; J.B. Lippincott Co.: Philadelphia, 1983.
25. Manual for Staging of Cancer, 3rd Ed.; Beahrs, O.H., Henson, D.E., Hutter, R.V.P., Meyers, M., Eds.; J.B. Lippincott Co.: Philadelphia, 1988.
26. Hutter, R.V. At last - worldwide agreement on the staging of cancer. Arch. Surg. 1987, 122, 1235-1239.
27. Bollschweiler, E.; Boettcher, K.; Hoelscher, A.H.; et al. Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer 1993, 71, 2918-2925.
28. Wanebo, H.J.; Kennedy, B.J.; Chmiel, J.; Steele, G., Jr.; Winchester, D.; Osteen, R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann. Surg. 1993, 218, 583-592.
29. Fielding, J.W. Gastric cancer: different diseases. Br. J. Surg. 1989, 76, 1227.
30. Kodama, Y.; Sugimachi, K.; Soejima, K.; Matsusaka, T.; Inokuchi, K. Evaluation of extensive lymph node dissection for carcinoma of the stomach. World J. Surg. 1981, 5, 241-248.
31. de Aretxabala, X.; Konishi, K.; Yonemura, Y.; et al. Node dissection in gastric cancer. Br. J. Surg. 1987, 74, 770-773.
32. Csendes, A.; Caracci, M.; Parr, G.; Pavez, J.; Venturelli, A. Clinical and therapeutic aspects of gastric cancer (1973-1979). A cooperative interhospital study. Rev. Med. Chile 1983, 111, 262-267.
33. Shiu, M.H.; Moore, E.; Sanders, M.; et al. Influence of the extent of resection on survival after curative treatment of gastric carcinoma: a retrospective multivariate analysis. Arch. Surg. 1987, 122, 1347-1351.
34. Hundahl, S.A.; Stemmermann, G.N.; Oishi, A. Racial factors cannot explain superior Japanese outcomes in stomach cancer. Arch. Surg. 1996, 131, 170-175.
35. Miwa, K. Evolution of the TNM classification of stomach cancer and proposal for its rational stage grouping. Jpn. J. Clin. Oncol. 1984, 14, 385-410.
36. Hundahl, S.A. Gastric cancer nodal metastases: biologic significance and therapeutic considerations. Surg. Oncol. Clin. N. Am. 1996, 5, 129-144.
37. Adam, Y.G.; Efron, G. Trends and controversies in the management of carcinoma of the stomach. Surg. Gynecol. Obstet. 1989, 169, 371-385.
38. Cady, B.; Rossi, R.L.; Silverman, M.L.; Piccione, W.; Heck, T.A. Gastric adenocarcinoma. A disease in transition. Arch. Surg. 1989, 124, 303-308.
39. Steele, R.J.; Chung, S.C.; Li, A.K.; Crofts, T.J. Hepatic metastases in Hong Kong Chinese: evidence for an East-West difference in gastric cancer. Ann. R. Coll. Surg. Engl. 1987, 69, 61-63.
40. Bodner, B.E. Will Rogers and gastric carcinoma. Arch. Surg. 1988, 123, 1023-1024.
41. Brennan, M.F. Radical surgery for gastric cancer. A review of the Japanese experience. Cancer 1989, 64, 2063.
42. Bunt, A.M.; Hermans, J.; Smit, V.T.; van de Velde, C.J.; Fleuren, G.J.; Bruijn, J.A. Surgical/pathologic-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J. Clin. Oncol. 1995, 13, 19-25.
43. Feinstein, A.R.; Sosin, D.A.; Wells, C.K. The Will Rogers phenomenon: improved technologic diagnosis and stage migration as a source of nontherapeutic improvement in cancer prognosis. Trans. Assoc. Am. Physicians 1984, 97, 19-24.
44. Bonenkamp, J.J.; van de Velde, C.J.; Kampschoer, G.H.; et al. Comparison of factors influencing the prognosis of Japanese, German, and Dutch gastric cancer patients. World J. Surg. 1993, 17, 410-414 discussion 415.
45. Cuschieri, A. Gastrectomy for gastric cancer: definitions and objectives. Br. J. Surg. 1986, 73, 513-514.
46. Douglas, H. R2 dissection in the treatment of gastric malignancy. Surg. Oncol. Clin. N. Am. 1993, 2, 413-431.
47. Lee, J.S.; Douglass, H.O., Jr. D2 dissection for gastric cancer. Surg. Oncol. 1997, 6, 215-225.
48. Douglass, H.O. Effect of lymph node dissection on survival of gastric carcinoma. J. Am. Coll. Surg. 1997, 184, 667-669.
49. Japanese Classification of Gastric Carcinoma, 1st English Ed.; Nishi, M., Omori, Y., Miwa, K., Eds.; Kanehara & Co., LTd.: Tokyo, 1995.
50. Dent, D.M. Radical surgery for curable gastric carcinoma. S. Afr. Med. J. 1994, 84, 56-57.
51. Dent, D.M.; Madden, M.V.; Price, S.K. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br. J. Surg. 1988, 75, 110-12.
52. Gouzi, J.L.; Huguier, M.; Fagniez, P.L.; et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum: a French prospective controlled study. Ann. Surg. 1989, 209, 162-166.
53. McNeer, G.; Bowden, L.; Booner, R.J.; McPeak, C.J. Elective total gastrectomy for cancer of the stomach: end results. Ann. Surg. 1974, 180, 252-256.
54. Bozzetti, F.; Marubini, E.; Bonfanti, G.; et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann. Surg. 1997, 226, 613-620.
55. Bozzetti, F.; Marubini, E.; Bonfanti, G.; Miceli, R.; Piano, C.; Gennari, L. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann. Surg. 1999, 230, 170-178.
56. Robertson, C.S.; Chung, S.C.; Woods, S.D.; et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann. Surg. 1994, 220, 176-182.
57. Cunha, P.; Cunha, J.F.; Burnay, M.O.; Galhordas, A.; Fernandes, R.; Calinas, F. Gastric adenocarcinoma and carcinoid. Acta Med. Port. 1998. 11, 577-580.
58. Cuschieri, A.; Fayers, P.; Fielding, J.; et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996, 347, 995-999.
59. Cuschieri, A.; Weeden, S.; Fielding, J.; et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br. J. Cancer 1999. 79, 1522-1530.
60. Maruyama, K.; Sasako, M.; Kinoshita, T.; Sano, T.; Katai, H.; Okajima, K. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J. Surg. 1995, 79, 532-536.
61. Uyama, I.; Ogiwara, H.; Takahara, T.; et al. Spleen- and pancreas-preserving total gastrectomy with superextended lymphadenectomy including dissection of the para-aortic lymph nodes for gastric cancer. J. Surg. Oncol. 1996, 63, 268-270.
62. Kaminishi, M.; Shimoyama, S.; Yamaguchi, H.; et al. Results of subtotal gastrectomy with complete dissection of the N2 lymph nodes preserving the spleen and pancreas in surgery for gastric cancer. Hepatogastroenterology 1994, 41, 384-387.
63. Bonenkamp, J.J.; Hermans, J.; Sasako, M.; van de Velde, C.J. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N. Engl. J. Med. 1999, 340, 908-914.
64. Bonenkamp, J.J.; Songun, I.; Hermans, J.; et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995, 345, 745-748.
65. Bunt, T.M.; Bonenkamp, H.J.; Hermans, J.; et al. Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer. Cancer 1994, 73, 1544-1551.
66. Hundahl, S.A. Surgical quality control in gastric cancer trials. Surg. Oncol. Clin. N. Am. 2002, 11, 445-458.
67. Sano, T. Update on D2 Versus D4 Trial; 4th International Gastric Cancer Congress: New York, 2001.
68. Baba, M.; Hokita, S.; Natsugoe, S.; et al. Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach. Hepato-gastroenterol. 2000, 47, 893-896.
69. De Manzoni, G.; Di Leo, A.; Guglielmi, A.; et al. Abdominal metastasis of cardias adenocarcinoma. Minerva Chir. 2000, 55, 105-111.
70. Kunisaki, C.; Shimada, H.; Yamaoka, H.; et al. Indications for paraaortic lymph node dissection in gastric cancer patients with paraaortic lymph node involvement. Hepato-gastroenterol. 2000, 47, 586-589.
71. Kunisaki, C.; Shimada, H.; Yamaoka, H.; et al. Significance of paraaortic lymph node dissection in advanced gastric cancer. Hepato-gastroenterol. 1999, 46, 2635-2642.
72. De Manzoni, G.; Di Leo, A.; Borzellino, G.; et al. Para-aortic lymph node involvement in gastric adenocarcinoma. Ann. Chir. 2001, 126, 302-306, discussion 306-307.
73. Nakajima, T.; Ota, K.; Ishihara, S.; Oyama, S.; Nishi, M.; Hamashima, N. Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH. Gan To Kagaku Ryoho 1994, 21, 1800-1805.
74. Pignon, J.P.; Ducreux, M.; Rougier, P. Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal. J. Clin. Oncol. 1994, 12, 877-878.
75. Mari, E.; Floriani, I.; Tinazzi, A.; et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann. Oncol. 2000, 11, 837-843.
76. Earle, C.C.; Maroun, J.A. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur. J. Cancer 1999, 35, 1059-1064.
77. Hu, J.K.; Chen, Z.X.; Zhou, Z.G.; et al. Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials. World J. Gastroenterol. 2002, 8, 1023-1028.
78. Panzini, I.; Gianni, L.; Fattori, P.P.; et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 2002, 88, 21-27.
79. Hermans, J.; Bonenkamp, J.J.; Boon, M.C.; et al. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J. Clin. Oncol. 1993, 11, 1441-1447.
80. Panzini, I.; Gianni, L.; Tassinari, D. Immunochemotherapy with OK-432 may improve survival for people with curatively resected gastric cancer. Abstracted from: Sakamoto J, Teramukai S, Nakazato H, et al. Efficacy of adjuvant immunochemotherapy with OK-432 for patients with curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials. J. Immunother. 2002, 25, 405-412.
81. Cancer Treat Rev 2003; 29:73-75.
82. Gunderson, L.L.; Martin, J.K.; O'Connell, M.J.; Beart, R.W.; Kvols, L.K.; Nagorney, D.M. Local control and survival in locally advanced gastrointestinal cancer. Int. J. Radiat. Oncol. Biol. Phys. 1986, 12, 661-665.
83. Gunderson, L.L.; Sosin, H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974, 34, 1278-1292.
84. Gunderson, L.L.; Sosin, H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) Clinicopathologic correlation and implications for adjuvant therapy. Int. J. Radiat. Oncol. Biol. Phys. 1982, 8, 1-11.
85. McNeer, G.; Vandenberg, H.; Donn, F.Y.; Bowden, L.A. A critical evaluation of subtotal gastrectomy for the cure of cancer of the stomach. Ann. Surg. 1951, 134, 2-7.
86. Landry, J.; Tepper, J.E.; Wood, W.C.; Moulton, E.O.; Koerner, F.; Sullinger, J. Patterns of failure following curative resection of gastric carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1990, 19, 1357-1362.
87. Takahashi, M.; Abe, M. Intra-operative radiotherapy for carcinoma of the stomach. Eur. J. Surg. Oncol. 1986, 12, 247-250.
88. Abe, M.; Nishimura, Y.; Shibamoto, Y. Intraoperative radiation therapy for gastric cancer. World J. Surg. 1995, 19, 544-547.
89. Moertel, C.G.; Gunderson, L.L.; Mailliard, J.A.; et al. Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group. J. Clin. Oncol. 1994, 12, 21-27.
90. O'Connell, M.J.; Gunderson, L.L.; Moertel, C.G.; Kvols, L.K. A pilot study to determine clinical tolerability of intensive combined modality therapy for locally unresectable gastric cancer. Int. J. Radiat. Oncol. Biol. Phys. 1985, 11, 1827-1831.
91. Bleiberg, H.; Goffin, J.C.; Dalesio, O.; et al. Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC. Eur. J. Surg. Oncol. 1989, 15, 535-543.
92. Macdonald, J.S.; Smalley, S.R.; Benedetti, J.; et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med. 2001, 345, 725-730.
93. Kelsen, D.P. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. J. Clin. Oncol. 2000. 18, 32S-34S.
94. Hundahl, S.A.; Macdonald, J.S.; Benedetti, J.; Fitzsimmons, T. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann. Surg. Oncol. 2002, 9, 278-286.
95. Hundahl, S.A. Surgical quality in trials of adjuvant cancer therapy. J. Surg. Oncol. 2002, 80, 177-180.
96. Schwarz, R.E. Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116. J. Clin. Oncol. 2001. 19, 1879-1880.
97. Kampschoer, G.H.; Maruyama, K.; van de Velde, C.J.; Sasako, M.; Kinoshita, T.; Okabayashi, K. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br. J. Surg. 1989, 76, 905-908.
98. Bollschweiler, E.; Boettcher, K.; Hoelscher, A.H.; et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program. Br. J. Surg. 1992, 79, 156-160.
99. Guadagni, S.; de Manzoni, G.; Catarci, M.; et al. Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer. World J. Surg. 2000, 24, 1550-1558.
100. Siewert, J.R.; Kelsen, D.; Maruyama, K.; et al. Gastric Cancer Diagnosis and Treatment-An Interactive Training Program; Spinger Electronic Media, 2000; Vol. 2000.
101. Peeters, K.C.M.J.; Hundahl, S.A.; Kranenbarg, E.K.; Hartgrink, H.; vandeVelde, C.J.H. "Low-Maruyama-Index" surgery for gastric cancer - a blinded re-analysis of the Dutch D1-D2 trial. World Journal of Surgery 2005; accepted and in press.